Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review
European Society for Medical Oncology · Fondazione IRCCS Istituto Nazionale dei Tumori · +18 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
283
total citations
- FWCI
- 61.52
- Percentile
- 100%
- References
- 169
Citations per year
Authors
30- APArsela PrelajCorresponding
European Society for Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Politecnico di Milano
- VMV. Miskovic
Fondazione IRCCS Istituto Nazionale dei Tumori, Politecnico di Milano
- MZMichele Zanitti
Aalborg University
- FTFrancesco Trovò
Politecnico di Milano
- CGCarlo Genova
Ospedale Policlinico San Martino, University of Genoa
Topics & keywords
Topics
Keywords
- Medicine
- Biomarker discovery
- Biomarker
- Oncology
- Internal medicine
- Medical physics
- Proteomics
No related works found for this paper.
Funding
- CRCancer Research Foundation
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- GSGilead Sciences
- ASAmerican Society of Clinical Oncology
- ACAdenoid Cystic Carcinoma Research Foundation
- CCelgene
- AAbbVie
- MKMerck KGaA
- FCFrancis Crick Institute
- EExelixis
- GAGordon and Rose McAlpine Foundation for Neuroscience Research
- LLLes Laboratories Pierre Fabre
- SSeagen
- CRCancer Research UK
- NINational Institute for Health and Care Research
- RTRosetrees Trust
- MDMinistero della Salute
- APAstellas Pharma
- ESEuropean Society for Medical Oncology
- BPBasilea Pharmaceutica
- SServier
- IItalfarmaco
- SMSirtex Medical
- GGenentech
- IIgnyta
- LOLoxo Oncology
- CCilag